Skip to main content
Novacyt logo

Novacyt — Investor Relations & Filings

Ticker · ALNOV ISIN · FR0010397232 LEI · 213800BWAC2BF295EG28 PA Manufacturing
Open in API
Filings indexed 1,101 across all filing types
Latest filing 2023-04-27 Investor Presentation
Country FR France
Listing PA ALNOV

About Novacyt

https://novacyt.com/

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Recent filings

Filing Released Lang Actions
2022 Full Year results presentation
Investor Presentation Classification · 95% confidence The document is a presentation titled '2022 Full Year results' containing forward-looking statements, management profiles, strategic vision, and financial highlights (including an income statement table). It is clearly designed for investors to review the company's performance and strategy. As it is a detailed presentation for investors focusing on financials and strategy, it fits the definition of an Investor Presentation. FY 2022
2023-04-27 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is a short announcement (4494 characters) released via RNS (RNS Number: 3393W) on April 17, 2023. The title explicitly states: "Notice of Full Year 2022 Results and Investor Presentation." It informs the market that the audited financial results for the year ended 31 December 2022 will be reported on a future date (April 27, 2023), and it also announces an associated investor webinar/presentation. Because this document is an announcement about the future publication of results and an associated presentation, rather than the full results (10-K or IR) or the presentation itself (IP), it fits the definition of a Report Publication Announcement (RPA).
2023-04-17 English
Liquidity Agreement and Total Voting Rights
Transaction in Own Shares Classification · 99% confidence The document is an official announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' and the concluding boilerplate text referencing RNS as the Primary Information Provider. The content specifically details the 'Liquidity Agreement Monthly Update' (share purchases/sales under the agreement) and the 'Total Voting Rights' as of March 31, 2023. This type of routine, mandatory disclosure regarding share structure and liquidity management, distributed through an official regulatory channel, fits best under the general 'Regulatory Filings' category (RNS), as it is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/board change announcement (MANG, DIRS). While it touches upon share activity, it is not a direct 'Transaction in Own Shares' (POS) but rather a report on the *liquidity provider's* activity, making RNS the most appropriate general regulatory classification.
2023-04-03 English
Information mensuelle sur le contrat de liquidite et sur le nombre total de drots de vote
Transaction in Own Shares Classification · 98% confidence The document is titled "Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote" (Monthly information on the liquidity contract and the total number of voting rights). It details the transactions (purchases and sales of shares) conducted by the liquidity provider (Invest Securities SA) during the period of March 1 to March 31, 2023, and reports the total number of voting rights as of March 31, 2023. This content specifically relates to the company's share repurchase/dealing activities under a liquidity agreement, which falls under the category of 'Transaction in Own Shares' (POS). It is not a general regulatory filing (RNS), an earnings release (ER), or a report on director dealings (DIRS), but a specific report on treasury stock management/share repurchase program execution.
2023-04-03 French
Liquidity Agreement and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content discusses a 'Liquidity Agreement Monthly Update' and provides the 'Total Voting Rights' as of February 28, 2023. This type of routine, mandatory disclosure, which is not a full financial report (like 10-K or IR) or a specific corporate action announcement (like DIV or SHA), fits best under the general regulatory announcement category. Since it is a standard regulatory news service release, the most appropriate code is RNS.
2023-03-01 English
Information mensuelle sur le contrat de liquidite et sur le nombre total de droits de vote
Declaration of Voting Results & Voting Rights Announcements Classification · 97% confidence The document is titled "Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote" (Monthly information on the liquidity contract and the total number of voting rights). It details the activity under a liquidity contract (share buybacks/sales) for the period February 1 to February 28, 2023, and reports the total number of voting rights as of February 28, 2023. This type of regular, periodic disclosure concerning share transactions (often related to market making or stabilization) and total share capital/voting rights is typically classified as a regulatory filing or a specific announcement related to share capital changes or insider activity. Since it specifically reports on the execution of a liquidity contract (share repurchase/dealing) and provides the total voting rights denominator, it aligns closely with 'Transaction in Own Shares' (POS) or a general 'Regulatory Filing' (RNS). Given the explicit focus on the monthly activity of the share repurchase/liquidity agreement, POS is the most specific fit, although it is a recurring report rather than a one-off transaction announcement. However, the content is a direct report of share transactions by a designated agent on behalf of the company, which falls under the scope of POS (Transaction in Own Shares). It is not a general earnings release (ER), interim report (IR), or a proxy statement (DEF 14A/PSI).
2023-02-28 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.